Solubility and Stability Enhanced Oral Formulations for the Anti-Infective Corallopyronin A

Novel-antibiotics are urgently needed to combat an increase in morbidity and mortality due to resistant bacteria. The preclinical candidate corallopyronin A (CorA) is a potent antibiotic against Gram-positive and some Gram-negative pathogens for which a solid oral formulation was needed for further...

Full description

Saved in:
Bibliographic Details
Published in:Pharmaceutics 2020-11, Vol.12 (11), p.1105
Main Authors: Krome, Anna K, Becker, Tim, Kehraus, Stefan, Schiefer, Andrea, Steinebach, Christian, Aden, Tilman, Frohberger, Stefan J, López Mármol, Álvaro, Kapote, Dnyaneshwar, Jansen, Rolf, Chaverra-Muñoz, Lillibeth, Hübner, Marc P, Pfarr, Kenneth, Hesterkamp, Thomas, Stadler, Marc, Gütschow, Michael, König, Gabriele M, Hoerauf, Achim, Wagner, Karl G
Format: Article
Language:English
Subjects:
anthelmintic
antibiotic
Antibiotics
Caustic soda
Chromatography
copovidone (PVP/VA)
corallopyronin A (CorA)
Ethanol
Polymers
Potassium
povidone (PVP)
RNA polymerase
solubility enhanced formulation
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Novel-antibiotics are urgently needed to combat an increase in morbidity and mortality due to resistant bacteria. The preclinical candidate corallopyronin A (CorA) is a potent antibiotic against Gram-positive and some Gram-negative pathogens for which a solid oral formulation was needed for further preclinical testing of the active pharmaceutical ingredient (API). The neat API CorA is poorly water-soluble and instable at room temperature, both crucial characteristics to be addressed and overcome for use as an oral antibiotic. Therefore, amorphous solid dispersion (ASD) was chosen as formulation principle. The formulations were prepared by spray-drying, comprising the water-soluble polymers povidone and copovidone. Stability (high-performance liquid chromatography, Fourier-transform-infrared spectroscopy, differential scanning calorimetry), dissolution (biphasic dissolution), and solubility (biphasic dissolution, Pion's T3 apparatus) properties were analyzed. Pharmacokinetic evaluations after intravenous and oral administration were conducted in BALB/c mice. The results demonstrated that the ASD formulation principle is a suitable stability- and solubility-enhancing oral formulation strategy for the API CorA to be used in preclinical and clinical trials and as a potential market product.
ISSN:1999-4923
1999-4923
DOI:10.3390/pharmaceutics12111105